Replies to post #171026 on Amarin Corp Plc (AMRN)

[Biobillionair]

The label Amarin will request is also covered:

sNDA for cardiovascular event prevention on-track to be submitted by end of Q1’19

Prevention is a very large market and includes all cardiovascular AT RISK PATIENTS. Market in US is >70 million patients.

BB